GLP-Reta is a breakthrough triple agonist that activates GLP-1, GIP, and glucagon receptors. This unique design has made it one of the most powerful peptides studied for weight management and metabolic health. By targeting three key pathways at once, GLP-Reta has provided researchers with an unmatched model for exploring appetite regulation, energy expenditure, and glucose balance. Beyond its physical effects, GLP-1–based research has also uncovered potential links to cognitive performance and neuroprotection, sparking interest in its role across both body and brain.
Research Outcomes in Studies:
Phase 2 obesity trial: average weight reductions of up to 24% over 48 weeks.
Significant improvements in insulin sensitivity and glucose control.
Dose-dependent decreases in BMI and waist circumference.
GLP-1 receptor research has shown cognitive and neuroprotective effects in preclinical and early clinical settings.
For laboratory research use only. Not for human or veterinary consumption. Not FDA evaluated.
- 10 mg vial = $80 → $8.00 per mg
- 30 mg vial = $160 → $5.33 per mg
👉 Choosing the 30 mg vial gives you the same potency per mg, with ~33% better value.